Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020240
Filing Date
2025-07-24
Accepted
2025-07-24 16:35:04
Documents
1
Period of Report
2025-07-23

Document Format Files

Seq Description Document Type Size
1 form4-07242025_040701.html 4  
1 form4-07242025_040701.xml 4 10580
  Complete submission text file 0001415889-25-020240.txt   12135
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ELEVATION ONCOLOGY 101 FEDERAL ST, STE. 1900 BOSTON MA 02110
Business Address
Mootz Darcy (Reporting) CIK: 0002005916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40523 | Film No.: 251147489